J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 51(10); 2008 > Article
Kim, Kim, and Suh: Updated Interventional Neuroradiology in the Neurovascular Diseases

Abstract

Rapid and continuous progression in the field of interventional neuroradiology (INR) has allowed many surgically difficult cranial vascular lesions to be treated effectively and less invasively. Development of high-resolution fluoroscopy and digital subtraction angiography also contributed to expansion of the role of the INR. The spectrum of INR application includes intracranial and extracranial stenosis, aneurysms, arteriovenous malformations, hypervascular tumors, and bleeding. Introduction of new devices and materials is so rapid that it is difficult to get outcome evaluation and reimbursement by the insurance which requires a long period of process. Role changes of the physicians and the hospitals seem to be considered for the patients who had required difficult surgery and perioperative surgical management.

References

1. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453.

2. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70~99%) or with mild (0~29%) carotid stenosis. Lancet 1991;337:1235-1243.

3. Theiss W, Hermanek P, Mathias K, Brückmann H, Dembski J, Hoffmann FJ, Kerner R, Leisch F, Mudra H, Schulte KL, Sievert H. German Society of Angiology/Vascular Medicine. German Society of Radiology. Predictors of Death and Stroke After Carotid Angioplasty and Stenting. A Subgroup Analysis of the Pro-CAS Data. Stroke 2008.

4. Suh DC, Lee SH, Kim KR, Park ST, Lim SM, Kim SJ, Choi CG, Lee HK. Pattern of atherosclerotic carotid stenosis in Korean patients with stroke: different involvement of intracranial versus extracranial vessels. AJNR Am J Neuroradiol 2003;24:239-244.

5. Suwanwela NC, Chutinetr A. Risk factors for atherosclerosis of cervicocerebral arteries: intracranial versus extracranial. Neuroepidemiology 2003;22:37-40.

6. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995;26:14-20.

7. Arenillas JF, Molina CA, Chacón P, Rovira A, Montaner J, Coscojuela P, Sánchez E, Quintana M, Alvarez-Sabín J. High lipoprotein (a), diabetes, and the extent of symptomatic intracranial athero-sclerosis. Neurology 2004;63:27-32.

8. Bang OY, Saver JL, Ovbiagele B, Choi YJ, Yoon SR, Lee KH. Adiponectin levels in patients with intracranial atherosclerosis. Neurology 2007;68:1931-1937.

9. Bang OY, Lee PH, Yoon SR, Lee MA, Joo IS, Huh K. Inflammatory markers, rather than conventional risk factors, are different between carotid and MCA atherosclerosis. J Neurol Neurosurg Psychiatry 2005;76:1128-1134.

10. Bang OY. Intracranial atherosclerotic stroke: specific focus on the metabolic syndrome and inflammation. Curr Atheroscler Rep 2006;8:330-336.

11. Park JH, Kwon HM, Roh JK. Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis. Eur J Neurol 2007;14:379-386.

12. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.

13. Saver JL. Intra-arterial thrombolysis. Neurology 2001;57:S58-S60.

14. Kim DJ. Guideline for intra-arterial thrombolysis of hyperacute ischemic stroke patients: Preliminary Report. Neurointervention 2007;2:17-23.

15. Orlandi G, Fanucchi S, Fioretti C, Acerbi G, Puglioli M, Padolecchia R, Sartucci F, Murri L. Characteristics of cerebral microembolism during carotid stenting and angioplasty alone. Arch Neurol 2001;58:1410-1413.

16. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Cutlip DE, Firth BG, Ouriel K. Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotidartery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493-1501.

17. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, Larrue V, Lièvre M, Leys D, Bonneville JF, Watelet J, Pruvo JP, Albucher JF, Viguier A, Piquet P, Garnier P, Viader F, Touzé E, Giroud M, Hosseini H, Pillet JC, Favrole P, Neau JP, Ducrocq X. EVA-3S Investigators. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;355:1660-1671.

18. SPACE Collaborative Group. Ringleb PA, Allenberg J, Brückmann H, Eckstein HH, Fraedrich G, Hartmann M, Hennerici M, Jansen O, Klein G, Kunze A, Marx P, Niederkorn K, Schmiedt W, Solymosi L, Stingele R, Zeumer H, Hacke W. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006;368:1239-1247.

19. Iyer SS, White CJ, Hopking LN, Katzen BT, Safian R, Whdey MH, Gray WA, Ciocca R, Bachinsky WB, Ansel G, Joey JD, Russell ME. BEACH Investigators. Carotid artery revasculaiization in high-surgical-risk patients using the Carotid WALLSTENT and Filter Wire EX / EZ: I-year outcomes in the BEACH Pirotal Group. J Am Coll Cardiol 2008;51:427-434.

20. Suh SI. Guideline for Extracranial Carotid Stenting: Preliminary Report. Neruointervention 2007;2:24-29.

21. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology 2003;22:106-117.

22. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004;35:1388-1392.

23. Henkes H, Miloslavski E, Lowens S, Reinartz J, Liebig T, Kuhne D. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 2005;47:222-228.

24. Suh DC, Kim JK, Choi JW, Choi BS, Pyun HW, Choi YJ, Kim MH, Yang HR, Ha HI, Kim SJ, Lee DH, Choi CG, Hahm KD, Kim JS. Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. AJNR Am J Neuroradiol 2008;29:781-785.

25. Lee B-H. Guideline for Intracranial Stenting of Symptomatic Intracranial Artery Stenosis: Preliminary Report. Neurointervention 2007;2.

26. Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007;38:2315-2321.

27. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2001;103:163-182.

28. Coull BM, Williams LS, Goldstein LB, Meschia JF, Heitzman D, Chaturvedi S, Johnston KC, Starkman S, Morgenstern LB, Wilterdink JL, Levine SR, Saver JL. American Academy of Neurology. American Stroke Association. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Neurology 2002;59:13-22.

29. Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 1998;29:251-256.

30. International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms-risk of rupture and risks of surgical intervention. N Engl J Med 1998;339:1725-1733.

31. Wiebers DO, Whisnant JP, Huston J 3rd, Meissner I, Brown RD Jr, Piepgras DG, Forbes GS, Thielen K, Nichols D, O'Fallon WM, Peacock J, Jaeger L, Kassell NF, Kongable-Beckman GL, Torner JC. International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003;362:103-110.

32. Baskaya MK, Heros RC. Indications for and complications of embolization of cerebral arteriovenous malformations. J Neurosurg 2006;104:183-186. discussion 186-187.

33. Katsaridis V, Papagiannaki C, Aimar E. Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology 2008.

34. Newton TH, Cronqvist S. Involvement of dural arteries in intracranial arteriovenous malformations. Radiology 1969;93:1071-1078.

35. Suh DC, Lee JH, Kim SJ, Chung SJ, Choi CG, Kim HJ, Kim CJ, KooK M, Ahn HS, Kwon SU, Kim JS. New concept in cavernous sinus dural arteriovenous fistula: correlation with presenting symptom and venous drainage patterns. New concept in cavernous sinus dural arteriovenous fistula: correlation with presenting symptom and venous drainage patterns. Stroke 2005;36:1134-1139.

36. Cognard C, Gobin YP, Pierot L, Bailly AL, Houdart E, Casasco A, Chiras J, Merland JJ. Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. Radiology 1995;194:671-680.

37. Borden JA, Wu JK, Shucart WA. A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment. J Neurosurg 1995;82:166-179.

38. Debrun G. Management of traumatic carotid-cavernous fistula 1992;New York: Raven Press.

39. Higashida RT, Halbach VV, Tsai FY, Norman D, Pribram HF, Mehringer CM, Hieshima GB. Interventional neurovascular treatment of traumatic carotid and vertebral artery lesions: results in 234 cases. AJR Am J Roentgenol 1989;153:577-582.

40. Lewis AI, Tomsick TA, Tew JM Jr, Lawless MA. Long-term results in direct carotid-cavernous fistulas after treatment with detachable balloons. J Neurosurg 1996;84:400-404.

41. Berenstein A, Lasjaunias P, Ter Brugge K. Surgical neuroangiography 2004;Berlin: Springer-Verlag.

42. Rodesch G, Lasjaunias P. Spinal cord arteriovenous shunts: from imaging to management. Eur J Radiol 2003;46:221-232.

43. Van Dijk JM, TerBrugge KG, Willinsky RA, Farb RI, Wallace MC. Multidisciplinary management of spinal dural arteriovenous fistulas: clinical presentation and long-term follow-up in 49 patients. Stroke 2002;33:1578-1583.

44. Schaat TJ, Salzman KL, Stevens EA. Sacral origin of a spinal dural arteriovenous fistula: case report and review. Spine 2002;27:893-897.

45. Westphal M, Koch C. Management of spinal dural arteriovenous fistulae using an interdisciplinary neuroradiological/ neurosurgical approach: experience with 47 cases. Neurosurgery 1999;45:451-457. discussion 457-458.

46. Rodesch G, Hurth M, Alvarez H, Tadie M, Lasjaunias P. Classification of spinal cord arteriovenous shunts: proposal for a reappraisal-the Bicetre experience with 155 consecutive patients treated between 1981 and 1999. Neurosurgery 2002;51:374-379. discussion 379-380.

47. Krings T, Chng SM, Ozanne A, Alvarez H, Rodesch G, Lasjaunias PL. Hereditary hemorrhagic telangiectasia in children: endovascular treatment of neurovascular malformations: results in 31 patients. Neuroradiology 2005;47:946-954.

48. Rodesch G, Hurth M, Alvarez H, Tadie M, Lasjaunias P. Spinal cord intradural arteriovenous fistulae: anatomic, clinical, and therapeutic considerations in a series of 32 consecutive patients seen between 1981 and 2000 with emphasis on endovascular therapy. Neurosurgery 2005;57:973-983. discussion 973-983.

49. Biondi A, Merland JJ, Hodes JE, Pruvo JP, Reizine D. Aneurysms of spinal arteries associated with intramedullary arteriovenous malformations. I. Angiographic and clinical aspects. AJNR Am J Neuroradiol 1992;13:913-922.

50. Rodesch G, Hurth M, Alvarez H, David P, Tadie M, Lasjaunias P. Embolization of spinal cord arteriovenous shunts: morphological and clinical follow-up and results-review of 69 consecutive cases. Neurosurgery 2003;53:40-49. discussion 49-50.

51. Konan AV, Raymond J, Roy D. Transarterial embolization of aneurysms associated with spinal cord arteriovenous malformations. Report of four cases. J Neurosurg 1999;90:148-154.

52. Corkill RA, Mitsos AP, Molyneux AJ. Embolization of spinal intramedullary arteriovenous malformations using the liquid embolic agent, Onyx: a single-center experience in a series of 17 patients. J Neurosurg Spine 2007;7:478-485.

53. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-422.

54. Werner JA, Dünne AA, Folz BJ, Rochels R, Bien S, Ramaswamy A, Lippert BM. Current concepts in the classification, diagnosis and treatment of hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol 2001;258:141-149.

55. Low DW. Hemangiomas and vascular malformations. Semin Pediatr Surg 1994;3:40-61.

56. Waner M, Suen JY, Dinehart S. Treatment of hemangiomas of the head and neck. Laryngoscope 1992;102:1123-1132.

57. Werner JA, Lippert BM, Gottschlich S, Folz BJ, Fleiner B, Hoeft S, Rudert H. Ultrasound-guided interstitial Nd: YAG laser treatment of voluminous hemangiomas and vascular malformations in 92 patients. Laryngoscope 1998;108:463-470.

58. Burrows PE, Lasjaunias PL, Ter Brugge KG, Flodmark O. Urgent and emergent embolization of lesions of the head and neck in children: indications and results. Pediatrics 1987;80:386-394.

59. Mulliken JB. Cutaneous vascular anomalies. Semin Vasc Surg 1993;6:204-218.

60. Ryu CW, Whang SM, Suh DC, Kim SM, Jang YJ, Kim HJ, Kim MJ, Chang SE, Hong JP, Kim SJ. Percutaneous direct puncture glue embolization of high-flow craniofacial arteriovenous lesions: a new circular ring compression device with a beveled edge. AJNR Am J Neuroradiol 2007;28:528-530.

61. Macpherson P. The value of pre-operative embolisation of meningioma estimated subjectively and objectively. Neuroradiology 1991;33:334-337.

62. Dean BL, Flom RA, Wallace RC, Khayata MH, Obuchowski NA, Hodak JA, Zabramski JM, Spetzler RF. Efficacy of endovascular treatment of meningiomas: evaluation with matched samples. AJNR Am J Neuroradiol 1994;15:1675-1680.

63. Gruber A, Bavinzski G, Killer M, Richling B. Preoperative embolization of hypervascular skull base tumors. Minim Invasive Neurosurg 2000;43:62-71.

64. Casasco A, Houdart E, Biondi A, Jhaveri HS, Herbreteau D, Aymard A, Merland JJ. Major complications of percutaneous embolization of skull-base tumors. AJNR Am J Neuroradiol 1999;20:179-181.

65. Sokoloff J, Wickbom I, McDonald D, Brahme F, Goergen TC, Goldberger LE. Therapeutic percutaneous embolization in intractable epistaxis. Radiology 1974;111:285-287.

66. Andersen PJ, Kjeldsen AD, Nepper-Rasmussen J. Selective embolization in the treatment of intractable epistaxis. Acta Otolaryngol 2005;125:293-297.

67. Gurney TA, Dowd CF, Murr AH. Embolization for the treatment of idiopathic posterior epistaxis. Am J Rhinol 2004;18:335-339.

68. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, Lutsep HL, Rymer MM, Higashida RT, Starkman S, Gobin YP, Frei D, Grobelny T, Hellinger F, Huddle D, Kidwell C, Koroshetz W, Marks M, Nesbit G, Silverman IE. Multi MERCI Investigators. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205-1212.

69. Varon J, Acosta P. Therapeutic hypothermia: past, present, and future. Chest 2008;133:1267-1274.

70. Rouhl RP, van Oostenbrugge RJ, Damoiseaux J, Cohen Tervaert JW, Lodder J. Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts. Stroke 2008;39:2158-2165.

71. Li Y, Chen J, Wang L, Lu M, Chopp M. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 2001;56:1666-1672.

72. Zlokovic BV, Apuzzo ML. Cellular and molecular neurosurgery: pathways from concept to reality-part II: vector systems and delivery methodologies for gene therapy of the central nervous system. Neurosurgery 1997;40:805-812. discussion 812-803.

Figure 1
A 72-year-old male presented with walking difficulty and sleeping tendency. He had hypertension,and artrial fibrillation. (A) Anterioposterior view of the right vertebral angiogram shows a stenosis of the right vertebralbasilar junction (VBJ) and occlusion of the left VBG. Note the anterior spinal artery (arrow) arising from the right VBJ precluding stenting at the right side. (B) Probing of the occluded left VBJ was possible to open the lumen with complete filling of the posterior circulation as shown in (C). Six month clinical follow-up showed improvement of his symptom and no evidence of stroke recurrence.
jkma-51-913-g001-l.jpg
Figure 2
A 59-year-old male with hypertension revealed an incidentally found an anterior communicating aneurysm on MR angiography (A). (B) Note broad neck of the aneurysm. (C) Balloon protection (arrow) of the neck was done during coiling of the aneurysm. (D) A stent was deployed for the small residual neck of the aneurysm (D). (E) 3D angiogram reveals a coiled mass (red mass) and stent marginal markers with red dots (arrows). There was no additional symptom or aneurysm filling (not shown) at 6 month follow-up.
jkma-51-913-g002-l.jpg
Figure 3
A 30-year-old female presented with progressive lower leg weakness and voiding disturbance for two months.
(A) Sagittal T2-weighted image shows a swollen edematous spinal cord (long arrow) and tortuous abnormal vessels (short arrow).
(B) The right L2 lumbar arteriogram showa a large feeder of the posterior spinal artery and nidus and dilated draining vein.
(C) selection angiogram shows the nidus.of spinal arteriovenous fistula.
(D) angiogram obtained after glue embolization.
(E) Two month follow-up MRI shows marked improvement of the swelling and edema of the spinal cord with improvement of her symptom.
jkma-51-913-g003-l.jpg


ABOUT
ARTICLE CATEGORY

Browse all articles >

ARCHIVES
FOR CONTRIBUTORS
Editorial Office
37 Ichon-ro 46-gil, Yongsan-gu, Seoul
Tel: +82-2-6350-6562    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2024 by Korean Medical Association.

Developed in M2PI

Close layer
prev next